Nuveen Asset Management LLC Lowers Position in HealthEquity, Inc. (NASDAQ:HQY)

Nuveen Asset Management LLC cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 9.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 548,725 shares of the company’s stock after selling 54,221 shares during the quarter. Nuveen Asset Management LLC’s holdings in HealthEquity were worth $52,650,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity during the 4th quarter worth $26,000. Transce3nd LLC purchased a new position in shares of HealthEquity during the 4th quarter worth $29,000. Smartleaf Asset Management LLC grew its holdings in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity during the 4th quarter worth $39,000. Finally, UMB Bank n.a. grew its holdings in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on HQY shares. KeyCorp lowered their price target on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Wells Fargo & Company increased their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. Finally, The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $111.75.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares of the company’s stock, valued at $6,597,842.85. This trade represents a 6.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

HealthEquity Price Performance

HQY stock opened at $98.23 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a market capitalization of $8.50 billion, a P/E ratio of 90.12, a P/E/G ratio of 1.60 and a beta of 0.45. The business’s 50-day moving average is $87.88 and its two-hundred day moving average is $97.12. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.